In keeping with its proactive stance on establishing a regulatory framework for the upcoming wave of AI-based software technologies, the FDA in February granted de novo authorization for the first AI-based product for acquiring cardiac ultrasound images. Deployment has begun in high-need acute point-of-care settings, including those treating COVID-19 patients.Subscribe now to read the full analysis
Welcome to MyStrategist, an online experience like no other in the medical device industry.
With MyStrategist, quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and MedTech Strategist Market Pathways – now on an all-in-one, digital platform. We invite you to explore our coverage.
Think Strategically. Subscribe Today.
Registration is now open for the 7th annual Innovation Summit Dublin, September 7-9, 2020. The industry's most anticipated event will sell out. Register Today.Register Learn More
Surgeons' go-to means of sensing cancer uses only the hands and the naked eye, resulting in imperfect outcomes and more procedures, both diagnostic and interventional, down the line. On Target Laboratories has formulated a fluorescent marker that attaches to cancer cells to minimize uncertainty from detection and enable more complete resections.Subscribe now to read the full analysis